Effects of myocardial postconditioning on the recruitment of endothelial progenitor cells

Journal of Interventional Cardiology

Volumn 25, Issue 2, 2012, Pages 103-110

  Jung, Christian ^a   Sörensson, Peder ^a   Saleh, Nawsad ^a   Arheden, Håkan ^b   Rydén, Lars ^a   Pernow, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CELL SUBPOPULATION; CLINICAL ARTICLE; CLINICAL STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; ISCHEMIC POSTCONDITIONING; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; ISCHEMIC POSTCONDITIONING; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; STEM CELLS;

EID: 84859700857     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00704.x     Document Type: Article

References (39)

1. Collard CD, Gelman S,. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001; 94: 1133-1138.
2. Piper HM, Meuter K, Schafer C,. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003; 75: S644-S648.
3. Penna C, Mancardi D, Raimondo S, et al,. The paradigm of postconditioning to protect the heart. J Cell Mol Med 2008; 12: 435-458.
4. Balakumar P, Rohilla A, Singh M,. Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: What could be the next footstep? Pharmacol Res 2008; 57: 403-412.
5. Darling CE, Jiang R, Maynard M, et al,. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: Role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-1626.
6. Sun HY, Wang NP, Halkos M, et al,. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006; 11: 1583-1593.
7. Zhao ZQ, Corvera JS, Halkos ME, et al,. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-588.
8. Na HS, Kim YI, Yoon YW, et al,. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 1996; 132: 78-83.
9. Schachinger V, Aicher A, Dobert N, et al,. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 2008; 118: 1425-1432.
10. Abdel-Latif A, Bolli R, Tleyjeh IM, et al,. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
11. Shintani S, Murohara T, Ikeda H, et al,. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779.
12. Grundmann F, Scheid C, Braun D, et al,. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol 2007; 96: 621-627.
13. Werner N, Kosiol S, Schiegl T, et al,. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
14. Sorensson P, Saleh N, Bouvier F, et al,. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010; 96: 1710-1715.
15. Fadini GP, Miorin M, Facco M, et al,. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457.
16. Jung C, Rafnsson A, Shemyakin A, et al,. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 2010; 3: 368-372.
17. Jung C, Fischer N, Fritzenwanger M, et al,. Endothelial progenitor cells in adolescents: Impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol 2009; 98: 179-188.
18. Hristov M, Schmitz S, Schuhmann C, et al,. An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood. Cytometry A 2009; 75: 848-853.
19. Engblom H, Hedström E, Heiberg E, et al,. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: One-year follow-up by MRI. Circ Cardiovasc Imaging 2009; 2: 47-55.
20. Heiberg E, Ugander M, Engblom H, et al,. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: Animal, phantom, and human study. Radiology 2008; 246: 581-588.
21. Sorensson P, Heiberg E, Saleh N, et al,. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010; 12: 25.
22. Heiberg E, Sjögren J, Ugander M, et al,. Design and validation of segment-freely available software for cardiovascular image analysis. BMC Med Imaging 2010; 11: 1.
23. Shantsila E, Watson T, Lip GY,. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007; 49: 741-752.
24. Brehm M, Ebner P, Picard F, et al,. Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI. Clin Res Cardiol 2009; 98: 477-486.
25. Leone AM, Valgimigli M, Giannico MB, et al,. From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells. Eur Heart J 2009; 30: 890-899.
26. Massa M, Rosti V, Ferrario M, et al,. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199-206.
27. George J, Goldstein E, Abashidze S, et al,. Circulating endothelial progenitor cells in patients with unstable angina: Association with systemic inflammation. Eur Heart J 2004; 25: 1003-1008.
28. Kunz GA, Liang G, Cuculi F, et al,. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-195.
29. Tang YL, Zhu W, Cheng M, et al,. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009; 104: 1209-1216.
30. Lin JS, Chen YS, Chiang HS, et al,. Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: Role of erythropoietin on progenitor cell mobilization. J Physiol 2008; 586: 5757-5769.
31. Li M, Nishimura H, Iwakura A, et al,. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005; 111: 1114-1120.
32. Nakamura S, Kimura M, Goto C, et al,. Cigarette smoking abolishes ischemic preconditioning-induced augmentation of endothelium-dependent vasodilation. Hypertension 2009; 53: 674-681.
33. Muller-Ehmsen J, Scheid C, Grundmann F, et al,. The mobilization of CD34 positive mononuclear cells after myocardial infarction is abolished by revascularization of the culprit vessel. Int J Cardiol 2005; 103: 7-11.
34. Leone AM, Rutella S, Bonanno G, et al,. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26: 1196-1204.
35. Wojakowski W, Tendera M,. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol 2005; 43: 229-232.
36. Furuya Y, Okazaki Y, Kaji K, et al,. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis. Rheumatology (Oxford) 2010; 49: 2375-2380.
37. Katsuki Y, Sasaki KI, Toyama Y, et al,. Early outgrowth EPCs generation is reduced in patients with Buerger's disease. Clin Res Cardiol 2010; 100: 21-27.
38. Granger DN, Rodrigues SF, Yildirim A, et al,. Microvascular responses to cardiovascular risk factors. Microcirculation 2010; 17: 192-205.
39. Shakoor SK, Aldibbiat A, Ingoe LE, et al,. Endothelial progenitor cells in subclinical hypothyroidism: The effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab 2010; 95: 319-322.